Estimated age (SD): mean age from SRBC was 29.9-yr (±6.8) vs. CVM 35.5-yr (±9.2) (p= 0.0006). Frequency analysis showed a greater proportion of shoulder and thoracic spine OA in CVM population (44% vs. 19.1% [p<0.009] and 36% vs. 6,8% [p=0.04], respectively). However, in SRBC population knee OA was more prevalent (67.4% vs. 52.5% [p<0.03]). A gender sub-analysis showed a greater proportion of male knee (68%) and lumbar spine (55%) OA vs. female 48% (p=0.016) and 46% (p<0.032), respectively. However, female displayed a greater proportion of elbow OA (46% vs. 33.8% [p<0.033]). Male agriculturalists showed a higher frequency of axial skeleton and shoulder OA when compared with hunter-gatherers males (p<0.02). Conversely, hunter-gatherers displayed a tendency to present more hip OA (p<0.057). Conclusions: Contributions of palaeorheumatology help to understand contemporary diseases. Results of this study support the notion that anatomic distribution of OA vary among different groups, and may be the consequence of biomechanical stress imposed by physical and occupational activities of ancient populations.
P343 SELECTIVE COX-2 INHIBITION IS BENEFICIAL FOR MATRIX TURNOVER OF OSTEOARTHRITIC CARTILAGE: A CLINICAL STUDY
S.C. Mastbergen 1 , A.M. Huisman 2 , A.A. Polak 2 , J.W. Bijlsma 1 , F.P. Lafeber 1 1 University Medical Center Utrecht, Utrecht, The Netherlands, 2 Sint Franciscus Gasthuis, Rotterdam, The Netherlands Purpose: Selective COX-2 inhibitors are prescribed for many disorders including osteoarthritis (OA) . Recent in vitro studies showed a positive direct effect of celecoxib, one of the selective COX-2 inhibitors, on human OA cartilage. Such effects are difficult to verify in a clinical trial because changes in OA cartilage, degenerative and reparative, are slow and evaluation of articular cartilage by imaging techniques is still hampered by their limited sensitivity. Therefore, we used an approach in which the benefits of in vivo treatment are combined with the benefits of ex vivo biochemical analyses of the cartilage. Methods: Patients with knee OA were treated 4 weeks prior to scheduled knee replacement surgery with celecoxib 2dd200mg, indomethacin 2dd50mg, or received no treatment. At joint replacement surgery, cartilage with underling bone was obtained from femoral condyles and tibial plateaus. The investigators were blinded to the patients' clinical data and medication use. Four randomly taken samples of each donor were used for histological grading of cartilage damage. In addition twenty randomly taken cartilage samples of each donor were used for biochemical analysis of proteoglycan (PG) synthesis, -retention, -release, -content, prostaglandin-E 2 (PGE 2 ) production. At least 8 donors per group were evaluated. Statistical evaluation of the effects of treatment was performed with an independent-sample T-test. p values less than or equal to 0,05 were considered statistically significant The study was conducted according to the declaration of Helsinki and received ethical approval in all centers. Results: Average age and gender were comparable between the different treatment groups. The average histological Mankin grade of cartilage damage ranged from 4 to 6 in the different groups and was not statistically significant different between groups. PGE 2 production was diminished for cartilage obtained from both treated groups when compared to the non treated patients (all p<0.05). The non-treated patients (controls) showed a proteoglycan synthesis rate, -retention, -release and -content typical for osteoarthritic cartilage. Patients who had used celecoxib showed a statistically significant higher proteoglycan synthesis compared to the controls (p<0.03) and a tendency towards a higher synthesis compared to the indomethacin group (p<0.09). The indomethacin treated group did not differ from the controls. This increased proteoglycan synthesis was accompanied by a better retention of the newly formed proteoglycans; celecoxib had a diminished release of newly formed PGs compared to the untreated controls (p<0.01) whereas indomethacin showed no difference compared to controls. Also for the total release of proteoglycans, the newly formed and the resident ones, significant lower values were found for celecoxib (p<0.01) treated patients compared to the non-treated controls. Indomethacin treatment showed a tendency towards a lower total proteoglycan release (p<0.10)Most interestingly, a treatment period of 4 weeks resulted even in a significant increase in proteoglycan content in the celecoxib compared to the controls (p<0.05) and compared to the indomethacin group (p<0.03). The indomethacin group showed even a tendency towards a lower content compared to the control patients (p<0.14). Conclusions: Using this novel approach we were able to demonstrate an in vivo generated beneficial effect of celecoxib, in contrast to indomethacin, on OA cartilage proteoglycan turnover.
P344 PATIENT SUBJECTIVE SATISFACTION AFTER KNEE ARTHROSCOPY FOR OSTEOARTHRITIS

M.A. Elsaid, A.M. Ali Barking Havering and Redbridge Hospitals NHS Trust, London, United Kingdom
Purpose: To assess patients' satisfaction after knee arthroscopy for degenerative knee disease, Osteoarthritis (OA). Methods: -In June 2005 a postal questionnaire was sent to 141 consecutive patients who underwent knee arthroscopy for osteoarthritis and had washout with or without debridment in order to assess their subjective satisfaction after the procedure.
-All these arthroscopies were performed in one theatre under the care of two orthopaedic consultants during the previous two years.
-The patients were asked to score their preoperative pain on a 1-10 scale.
-Satisfaction assessment was based on a simple core question; how do they consider their knees at the time of the questionnaire pain wise and function wise (Same or worse coded unsatisfied and better coded satisfied).
-Then their notes were reviewed to assess any preoperative mechanical symptoms (Clicking, locking or giving way), associated element of trauma, the degree of osteoarthritis they had at the time of arthroscopy, the immediate post operative recovery period and the outpatient clinic follow up records. -These patients were divided into two groups, A -with no preoperative mechanical symptoms B -with preoperative mechanical symptoms Results: -Out of the 141 patients a total of 107 (75.5%) returned the fully completed questionnaire. Of these, 8 (5.7%) were excluded because of associated history of trauma and 7(5%) were excluded because of insufficient information or their notes were not available.
-The average follow up was 13 months (Range 2-24 months). -The age, sex distribution, preoperative pain score (A=7.6 versus B=8) and the degree of OA (grade 1-3) in both groups were comparable. -Patients satisfaction was: Group A: 32 (74.5%) satisfied, 11(26%) unsatisfied Group B: 22 (44.9%) satisfied, 27(55%) unsatisfied With a P value of 0.0057
